menu
    • menu

    Company profile for Eupraxia Pharmaceuticals

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our patient-centric approach targets the areas of greatest need – where we can help patients and their healthcare providers achieve the best outcomes.Our focus goes beyond doing things right – we want to ensure we do the right things. Our experienced leadership inspires excellence at all levels – in ourselves, our team and our goals.We believe that creativity is more likely to happen in the right environment, so we have...
    Our patient-centric approach targets the areas of greatest need – where we can help patients and their healthcare providers achieve the best outcomes.Our focus goes beyond doing things right – we want to ensure we do the right things. Our experienced leadership inspires excellence at all levels – in ourselves, our team and our goals.We believe that creativity is more likely to happen in the right environment, so we have shaped a corporate culture that fosters ingenuity, passion and the freedom to explore.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Eupraxia PharmaceuticalsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    201-2067 Cadboro Bay Rd. Victoria BC
    Telephone
    Telephone
    250-590-3968
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.eupraxiapharma.com/home/default.aspx
    Linkedin
    Linkedin
    https://www.linkedin.com/company/eupraxia-pharmaceuticals-inc-/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/eupraxia_pharma?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eupraxia Pharma Reveals 52-Week RESOLVE Trial Follow-Up Data
    Eupraxia Pharma Reveals 52-Week RESOLVE Trial Follow-Up Data

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187915/0/en/Eupraxia-Pharmaceuticals-Reports-Additional-52-week-Follow-up-Data-from-the-RESOLVE-Trial-in-Eosinophilic-Esophagitis-EoE-Demonstrating-Consistent-Results-after-Dosing-with-EP-104G.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    Eupraxia Pharma Reveals Q3 2025 Financials Updates
    Eupraxia Pharma Reveals Q3 2025 Financials Updates

    04 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/04/3180937/0/en/Eupraxia-Pharmaceuticals-Reports-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    04 Nov 2025
    Share Share
    Eupraxia Pharma Reveals Strong Results In RESOLVE Trial
    Eupraxia Pharma Reveals Strong Results In RESOLVE Trial

    29 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/29/3158170/0/en/Eupraxia-Pharmaceuticals-Announces-Positive-Data-from-Highest-Dose-Cohort-in-the-Ongoing-RESOLVE-Trial-in-Eosinophilic-Esophagitis-and-Plans-for-Expansion-of-EP-104GI-Development-P.html

    GLOBENEWSWIRE
    29 Sep 2025
    Share Share
    Eupraxia Pharma Announces Proposed Public Offering of Shares
    Eupraxia Pharma Announces Proposed Public Offering of Shares

    22 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/22/3154291/0/en/Eupraxia-Pharmaceuticals-Announces-Proposed-Public-Offering-of-Common-Shares.html

    GLOBENEWSWIRE
    22 Sep 2025
    Share Share
    Eupraxia Pharma Prices $70m Public Offering Of Common Shares
    Eupraxia Pharma Prices $70m Public Offering Of Common Shares

    22 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/23/3154374/0/en/Eupraxia-Pharmaceuticals-Announces-Pricing-of-US-70-Million-Public-Offering-of-Common-Shares.html

    GLOBENEWSWIRE
    22 Sep 2025
    Share Share
    Resolve Trial Shows EP-104GI Yields Lasting EoE Symptom Relief
    Resolve Trial Shows EP-104GI Yields Lasting EoE Symptom Relief

    02 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/02/3142594/0/en/First-Set-of-1-Year-Clinical-Results-from-RESOLVE-Trial-in-Eosinophilic-Esophagitis-EoE-Durable-and-Sustained-Symptom-Tissue-Responses-after-Dosing-with-EP-104GI.html

    GLOBENEWSWIRE
    02 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search